SUPPLEMENT

Q3 2026 — Financial data tables

Q3 2026PDF · 12 pages181 KB
Section Page No.
Trended Unaudited Quarterly and Annual Condensed Consolidated Statements of Income (GAAP) and Other
Metrics
2
Trended Unaudited Quarterly and Annual Non-GAAP Financial Measures 3
Trended Unaudited Quarterly and Annual Procedures, Revenue, and Related Metrics - Worldwide 4
Trended Unaudited Quarterly and Annual Procedures, Revenue, and Related Metrics - By Geography 5
Trended Unaudited Quarterly and Annual Procedures, Revenue, and Related Metrics - Da Vinci Worldwide 6
Trended Unaudited Quarterly and Annual Procedures, Revenue, and Related Metrics - Da Vinci by
Geography
7
Trended Unaudited Quarterly and Annual Procedures, Revenue, and Related Metrics - Ion Worldwide 8
Reconciliation of Unaudited GAAP to Non-GAAP Financial Measures 9
INTUITIVE SURGICAL, INC.
TABLE OF CONTENTS

-- 1 of 12 --

Condensed Consolidated Statements of Income
Revenue $ 1,890.6 $ 2,009.9 $ 2,038.1 $ 2,413.5 $ 2,253.4 $ 2,440.0 $ 2,505.1 $ 2,866.2 $ 2,770.8 $ 2,892.3 $ 3,048.7 $ 8,352.1 $ 10,064.7 $ 8,711.8
Gross Profit 1,245.4 1,372.7 1,373.9 1,642.2 1,457.7 1,617.9 1,662.4 1,904.3 1,830.5 1,960.4 2,084.3 5,634.2 6,642.3 5,875.2
Gross Profit Margin 65.9% 68.3% 67.4% 68.0% 64.7% 66.3% 66.4% 66.4% 66.1% 67.8% 68.4% 67.5% 66.0% 67.4%
Selling, General, and Administrative (“SG&A”) Expenses 491.5 525.3 510.6 612.6 563.4 561.2 573.3 687.1 613.3 617.9 1,083.4 2,140.0 2,385.0 2,314.6
Research and Development (“R&D”) Expenses 284.5 280.1 286.0 294.7 316.2 313.3 329.4 352.9 361.9 370.6 408.3 1,145.3 1,311.8 1,140.8
Total Operating Expenses 776.0 805.4 796.6 907.3 879.6 874.5 902.7 1,040.0 975.2 988.5 1,491.7 3,285.3 3,696.8 3,455.4
Income from Operations 469.4 567.3 577.3 734.9 578.1 743.4 759.7 864.3 855.3 971.9 592.6 2,348.9 2,945.5 2,419.8
Operating Margin 24.8% 28.2% 28.3% 30.4% 25.7% 30.5% 30.3% 30.2% 30.9% 33.6% 19.4% 28.1% 29.3% 27.8%
Interest and Other Income, Net 69.1 87.2 93.7 74.9 90.4 88.7 95.5 91.3 85.1 82.7 75.8 324.9 365.9 243.6
Income Before Taxes 538.5 654.5 671.0 809.8 668.5 832.1 855.2 955.6 940.4 1,054.6 668.4 2,673.8 3,311.4 2,663.4
Income Tax Expense (Benefit) (8.9) 123.0 100.4 121.8 (35.2) 167.9 146.0 156.1 114.4 231.4 144.0 336.3 434.8 489.8
Effective Tax Rate (1.7)% 18.8% 15.0% 15.0% (5.3)% 20.2% 17.1% 16.3% 12.2% 21.9% 21.5% 12.6% 13.1% 18.4%
Net Income 547.4 531.5 570.6 688.0 703.7 664.2 709.2 799.5 826.0 823.2 524.4 2,337.5 2,876.6 2,173.6
Less: Net Income Attributable to Noncontrolling
Interest in Joint Venture 2.5 4.6 5.5 2.3 5.3 5.8 4.8 4.7 4.5 5.1 1.6 14.9 20.6 11.2
Net Income Attributable to Intuitive Surgical, Inc. $ 544.9 $ 526.9 $ 565.1 $ 685.7 $ 698.4 $ 658.4 $ 704.4 $ 794.8 $ 821.5 $ 818.1 $ 522.8 $ 2,322.6 $ 2,856.0 $ 2,162.4
Net Income Per Share Attributable to Intuitive
Surgical, Inc. $ 1.51 $ 1.46 $ 1.56 $ 1.88 $ 1.92 $ 1.81 $ 1.95 $ 2.21 $ 2.28 $ 2.29 $ 1.49 $ 6.42 $ 7.87 $ 6.07
Diluted Shares Outstanding 360.5 361.0 362.7 363.9 364.6 364.1 361.8 360.4 359.8 357.3 351.6 362.0 362.7 356.2
Other Metrics
Cash and Investments $ 7,323 $ 7,683 $ 8,312 $ 8,832 $ 9,101 $ 9,533 $ 8,433 $ 9,034 $ 7,979 $ 8,626 $ 6,800 $ 8,832 $ 9,034 $ 6,800
Capital Expenditures and Acquisitions $ 243.6 $ 310.3 $ 248.3 $ 313.0 $ 116.6 $ 156.5 $ 105.4 $ 175.2 $ 631.5 $ 112.6 $ 103.5 $ 1,115.2 $ 553.7 $ 847.6
Share Repurchases $ — $ — $ — $ — $ — $ 181.0 $ 1,919.6 $ 200.3 $ 1,127.5 $ 379.0 $ 2,939.8 $ — $ 2,300.9 $ 4,446.3
Headcount 14,118 14,668 15,333 15,638 16,173 16,475 16,813 17,021 17,446 17,661 18,169 15,638 17,021 18,169
Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 FY24 FY25 FY26
YTD
Intuitive Surgical, Inc.
Trended Unaudited Quarterly and Annual Condensed Consolidated Statements of Income (GAAP) and Other Metrics
(in millions, except per share data and headcount)
2024 - 2026
Page 2 of 12

-- 2 of 12 --

Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 FY24 FY25 FY26
YTD
Non-GAAP Gross Profit Margin 67.6% 70.0% 69.1% 69.5% 66.4% 67.9% 68.0% 67.8% 67.8% 70.0% 69.9% 69.1% 67.6% 69.2%
Non-GAAP SG&A Expenses $ 422.2 $ 438.1 $ 432.7 $ 522.2 $ 482.2 $ 472.4 $ 476.7 $ 599.3 $ 522.5 $ 522.1 $ 539.2 $ 1,815.2 $ 2,030.6 $ 1,583.8
Non-GAAP R&D Expenses $ 226.4 $ 214.0 $ 220.2 $ 228.5 $ 246.9 $ 238.1 $ 251.2 $ 272.4 $ 279.8 $ 283.8 $ 320.7 $ 889.1 $ 1,008.6 $ 884.3
Non-GAAP Operating Margin 33.3% 37.5% 37.0% 38.4% 34.1% 38.8% 39.0% 37.3% 38.9% 42.1% 41.6% 36.7% 37.4% 40.9%
Non-GAAP Income Before Taxes $ 702.5 $ 833.5 $ 849.5 $ 1,015.3 $ 858.5 $ 1,039.7 $ 1,068.4 $ 1,156.8 $ 1,161.3 $ 1,300.5 $ 1,344.6 $ 3,400.8 $ 4,123.4 $ 3,806.4
Non-GAAP Net Income Attributable to Intuitive
Surgical, Inc. $ 541.1 $ 641.0 $ 669.1 $ 804.7 $ 661.5 $ 797.9 $ 867.2 $ 913.6 $ 901.1 $ 1,002.1 $ 1,054.5 $ 2,655.9 $ 3,240.2 $ 2,957.7
Non-GAAP Net Income Per Share Attributable to
Intuitive Surgical, Inc. $ 1.50 $ 1.78 $ 1.84 $ 2.21 $ 1.81 $ 2.19 $ 2.40 $ 2.53 $ 2.50 $ 2.80 $ 3.00 $ 7.34 $ 8.93 $ 8.30
Diluted Shares Outstanding 360.5 361.0 362.7 363.9 364.6 364.1 361.8 360.4 359.8 357.3 351.6 362.0 362.7 356.2
Intuitive Surgical, Inc.
Trended Unaudited Quarterly and Annual Non-GAAP Financial Measures (#)
(in millions, except per share data)
2024 - 2026
Page 3 of 12

-- 3 of 12 --

Revenue and Related Metrics
Instruments and Accessories Revenue (millions) $ 1,158.9 $ 1,244.4 $ 1,264.2 $ 1,411.5 $ 1,367.7 $ 1,474.1 $ 1,518.8 $ 1,658.3 $ 1,686.4 $ 1,734.9 $ 1,797.4 $ 5,079.0 $ 6,018.9 $ 5,218.7
Year-over-year growth 18% 16% 18% 23% 18% 18% 20% 17% 23% 18% 18% 19% 19% 20%
Quarter-over-quarter growth (decline) 1% 7% 2% 12% (3)% 8% 3% 9% 2% 3% 4%
Year-over-year da Vinci procedure growth 16% 17% 18% 18% 17% 17% 19% 17% 16% 15% 14% 17% 18% 15%
Quarter-over-quarter da Vinci procedure growth 2% 6% 1% 8% 1% 6% 3% 7% —% 5% 2%
Service Revenue (millions) $ 313.5 $ 317.3 $ 328.9 $ 347.4 $ 363.0 $ 391.2 $ 395.9 $ 422.0 $ 433.7 $ 472.4 $ 482.2 $ 1,307.1 $ 1,572.1 $ 1,388.3
Year-over-year growth 11% 10% 12% 14% 16% 23% 20% 21% 19% 21% 22% 12% 20% 21%
Quarter-over-quarter growth 3% 1% 4% 6% 4% 8% 1% 7% 3% 9% 2%
Operating Lease Revenue (millions) $ 148.0 $ 156.9 $ 167.8 $ 181.5 $ 195.2 $ 213.8 $ 223.0 $ 242.3 $ 250.2 $ 261.8 $ 275.0 $ 654.2 $ 874.3 $ 787.0
Year-over-year growth 32% 28% 32% 31% 32% 36% 33% 33% 28% 22% 23% 31% 34% 25%
Quarter-over-quarter growth 7% 6% 7% 8% 8% 10% 4% 9% 3% 5% 5%
Total Recurring Revenue (millions) (1) $ 1,620.4 $ 1,718.6 $ 1,760.9 $ 1,940.4 $ 1,925.9 $ 2,079.1 $ 2,137.7 $ 2,322.6 $ 2,370.3 $ 2,469.1 $ 2,554.6 $ 7,040.3 $ 8,465.3 $ 7,394.0
Year-over-year growth 17% 16% 18% 22% 19% 21% 21% 20% 23% 19% 20% 18% 20% 20%
Quarter-over-quarter growth (decline) 2% 6% 2% 10% (1)% 8% 3% 9% 2% 4% 3%
% Recurring Revenue 86% 86% 86% 80% 85% 85% 85% 81% 86% 85% 84% 84% 84% 85%
Systems Revenue (millions) $ 418.2 $ 448.2 $ 445.0 $ 654.6 $ 522.7 $ 574.7 $ 590.4 $ 785.9 $ 650.7 $ 685.0 $ 769.1 $ 1,966.0 $ 2,473.7 $ 2,104.8
Year-over-year growth (decline) (2)% 14% 17% 36% 25% 28% 33% 20% 24% 19% 30% 17% 26% 25%
Quarter-over-quarter growth (decline) (13)% 7% (1)% 47% (20)% 10% 3% 33% (17)% 5% 12%
Total Revenue (millions) (2) $ 1,890.6 $ 2,009.9 $ 2,038.1 $ 2,413.5 $ 2,253.4 $ 2,440.0 $ 2,505.1 $ 2,866.2 $ 2,770.8 $ 2,892.3 $ 3,048.7 $ 8,352.1 $ 10,064.7 $ 8,711.8
Year-over-year growth 11% 14% 17% 25% 19% 21% 23% 19% 23% 19% 22% 17% 21% 21%
Quarter-over-quarter growth (decline) (2)% 6% 1% 18% (7)% 8% 3% 14% (3)% 4% 5%
___________
(1) We present operating lease revenue, which is classified as systems revenue, as a component of total recurring revenue.
(2) Total revenue consists of instruments and accessories revenue, service revenue, and systems revenue.
Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 FY24 FY25 FY26
YTD
Intuitive Surgical, Inc.
Trended Unaudited Quarterly and Annual Procedures, Revenue, and Related Metrics
Worldwide
2024 - 2026
Page 4 of 12

-- 4 of 12 --

U.S. Revenue and Related Metrics
Instruments and Accessories Revenue (millions) $ 822.4 $ 891.4 $ 904.8 $ 1,007.8 $ 963.8 $ 1,017.3 $ 1,062.0 $ 1,160.3 $ 1,121.8 $ 1,180.4 $ 1,247.9 $ 3,626.4 $ 4,203.4 $ 3,550.1
Year-over-year growth 17% 17% 17% 23% 17% 14% 17% 15% 16% 16% 18% 19% 16% 17%
Quarter-over-quarter growth (decline) —% 8% 2% 11% (4)% 6% 4% 9% (3)% 5% 6%
Year-over-year da Vinci procedure growth 14% 14% 16% 15% 13% 14% 16% 15% 14% 12% 10% 15% 15 % 12%
Quarter-over-quarter da Vinci procedure growth (decline) —% 5% 1% 8% (2)% 6% 2% 7% (3)% 4% 1%
Service Revenue (millions) $ 203.6 $ 203.5 $ 209.2 $ 224.1 $ 238.5 $ 258.1 $ 258.1 $ 275.9 $ 281.7 $ 310.7 $ 309.6 $ 840.4 $ 1,030.6 $ 902.0
Year-over-year growth 9% 7% 11% 13% 17% 27% 23% 23% 18% 20% 20% 10% 23% 20%
Quarter-over-quarter growth 2% —% 3% 7% 6% 8% —% 7% 2% 10% —%
Systems Revenue (millions) $ 212.5 $ 224.3 $ 265.4 $ 420.4 $ 335.9 $ 354.0 $ 397.5 $ 494.4 $ 379.8 $ 442.1 $ 505.5 $ 1,122.6 $ 1,581.8 $ 1,327.4
Year-over-year growth (decline) (4)% 18% 23% 77% 58% 58% 50% 18% 13% 25% 27% 30% 41% 22%
Quarter-over-quarter growth (decline) (11)% 6% 18% 58% (20)% 5% 12% 24% (23)% 16% 14%
Total Revenue (millions) $ 1,238.5 $ 1,319.2 $ 1,379.4 $ 1,652.3 $ 1,538.2 $ 1,629.4 $ 1,717.6 $ 1,930.6 $ 1,783.3 $ 1,933.2 $ 2,063.0 $ 5,589.4 $ 6,815.8 $ 5,779.5
Year-over-year growth 12% 15% 17% 32% 24% 24% 25% 17% 16% 19% 20% 19% 22% 18%
Quarter-over-quarter growth (decline) (1)% 7% 5% 20% (7)% 6% 5% 12% (8)% 8% 7%
OUS Revenue and Related Metrics
Instruments and Accessories Revenue (millions) $ 336.5 $ 353.0 $ 359.4 $ 403.7 $ 403.9 $ 456.8 $ 456.8 $ 498.0 $ 564.6 $ 554.5 $ 549.5 $ 1,452.6 $ 1,815.5 $ 1,668.6
Year-over-year growth 18% 13% 22% 24% 20% 29% 27% 23% 40% 21% 20% 19% 25% 27%
Quarter-over-quarter growth (decline) 4% 5% 2% 12% —% 13% —% 9% 13% (2)% (1)%
Year-over-year da Vinci procedure growth 20% 22% 24% 25% 24% 23% 24% 21% 19% 20% 20% 23% 23% 20%
Quarter-over-quarter da Vinci procedure growth 7% 6% 2% 8% 6% 5% 3% 5% 5% 6% 3%
Service Revenue (millions) $ 109.9 $ 113.8 $ 119.7 $ 123.3 $ 124.5 $ 133.1 $ 137.8 $ 146.1 $ 152.0 $ 161.7 $ 172.6 $ 466.7 $ 541.5 $ 486.3
Year-over-year growth 14% 16% 15% 17% 13% 17% 15% 18% 22% 21% 25% 15% 16% 23%
Quarter-over-quarter growth 4% 4% 5% 3% 1% 7% 4% 6% 4% 6% 7%
Systems Revenue (millions) $ 205.7 $ 223.9 $ 179.6 $ 234.2 $ 186.8 $ 220.7 $ 192.9 $ 291.5 $ 270.9 $ 242.9 $ 263.6 $ 843.4 $ 891.9 $ 777.4
Year-over-year growth (decline) —% 10% 10% (3)% (9)% (1)% 7% 24% 45% 10% 37% 4% 6% 29%
Quarter-over-quarter growth (decline) (15)% 9% (20)% 30% (20)% 18% (13)% 51% (7)% (10)% 9%
Total Revenue (millions) $ 652.1 $ 690.7 $ 658.7 $ 761.2 $ 715.2 $ 810.6 $ 787.5 $ 935.6 $ 987.5 $ 959.1 $ 985.7 $ 2,762.7 $ 3,248.9 $ 2,932.3
Year-over-year growth 11% 13% 17% 13% 10% 17% 20% 23% 38% 18% 25% 13% 18% 27%
Quarter-over-quarter growth (decline) (3)% 6% (5)% 16% (6)% 13% (3)% 19% 6% (3)% 3%
Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 FY24 FY25 FY26
YTD
Intuitive Surgical, Inc.
Trended Unaudited Quarterly and Annual Procedures, Revenue, and Related Metrics
By Geography
2024 - 2026
Page 5 of 12

-- 5 of 12 --

Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 FY24 FY25 FY26
YTD
Da Vinci System Installed Base Rollforward
Beginning da Vinci System Installed Base 8,606 8,887 9,203 9,539 9,902 10,189 10,488 10,763 11,106 11,395 11,710 8,606 9,902 11,106
Systems Placed:
Dual Console da Vinci X Systems — 3 — 2 — 2 1 3 3 — 1 5 6 4
Single Console da Vinci X Systems 38 38 47 47 38 47 41 35 38 58 36 170 161 132
Dual Console da Vinci Xi Systems 58 44 45 76 40 21 34 32 34 19 23 223 127 76
Single Console da Vinci Xi Systems 185 165 156 164 123 122 81 124 90 107 129 670 450 326
Dual Console da Vinci 5 Systems — 4 8 46 35 56 77 130 93 114 124 58 298 331
Single Console da Vinci 5 Systems 8 66 102 128 112 124 163 173 139 132 191 304 572 462
Da Vinci SP Systems 24 21 21 30 19 23 30 35 34 38 42 96 107 114
Total System Units Placed (1) 313 341 379 493 367 395 427 532 431 468 546 1,526 1,721 1,445
Trade-Ins, Lease Upgrades, and Retirements (3) (32) (25) (43) (130) (80) (96) (152) (189) (142) (153) (162) (230) (517) (457)
Ending da Vinci System Installed Base (2) 8,887 9,203 9,539 9,902 10,189 10,488 10,763 11,106 11,395 11,710 12,094 9,902 11,106 12,094
___________
(1) Includes da Vinci systems placed under the following operating leasing arrangements:
Fixed-Payment 65 83 79 82 91 69 116 100 125 123 131 309 376 379
% of Total da Vinci Units Placed 21% 24% 21% 17% 25% 17% 27% 19% 29% 26% 24% 20% 22% 26%
Usage-Based 94 92 141 140 107 124 115 150 118 131 160 467 496 409
% of Total da Vinci Units Placed 30% 27% 37% 28% 29% 31% 27% 28% 27% 28% 29% 31% 29% 28%
(2) Includes da Vinci systems under the following operating leasing arrangements:
Fixed-Payment 1,223 1,261 1,289 1,307 1,308 1,301 1,379 1,400 1,477 1,522 1,581 1,307 1,400 1,581
% of Total da Vinci Installed Base 14% 14% 14% 13% 13% 12% 13% 13% 13% 13% 13% 13% 13% 13%
Usage-Based 1,112 1,208 1,352 1,492 1,598 1,686 1,736 1,810 1,848 1,903 1,974 1,492 1,810 1,974
% of Total da Vinci Installed Base 13% 13% 14% 15% 16% 16% 16% 16% 16% 16% 16% 15% 16% 16%
(3) During the fourth quarter of 2025 and 2024, we performed a verification audit of our installed base records that identified 22 and 54 systems, respectively, mostly older S and Si models, which had been retired.
We removed these systems from our installed base estimate during the fourth quarter of 2025 and 2024.
Other Metrics (in thousands)
Da Vinci Procedures 627 661 670 725 732 775 797 849 847 889 906 2,683 3,153 2,642
U.S. 412 433 438 474 465 495 507 545 528 552 559 1,757 2,012 1,639
OUS 215 228 232 251 267 280 290 304 319 337 347 926 1,141 1,003
Da Vinci Instruments and Accessories Revenue per
Procedure $ 1.78 $ 1.79 $ 1.80 $ 1.86 $ 1.78 $ 1.80 $ 1.80 $ 1.85 $ 1.88 $ 1.83 $ 1.86 $ 1.81 $ 1.81 $ 1.86
Da Vinci System Average Selling Price $ 1,380 $ 1,440 $ 1,510 $ 1,590 $ 1,620 $ 1,500 $ 1,600 $ 1,680 $ 1,740 $ 1,590 $ 1,610 $ 1,500 $ 1,600 $ 1,640
Intuitive Surgical, Inc.
Trended Unaudited Quarterly and Annual Procedures, Revenue, and Related Metrics
Da Vinci Worldwide
2024 - 2026
Page 6 of 12

-- 6 of 12 --

U.S. da Vinci System Installed Base Rollforward
Beginning da Vinci System Installed Base 5,111 5,243 5,385 5,582 5,807 5,957 6,087 6,223 6,364 6,477 6,615 5,111 5,807 6,364
Systems Placed:
Single Console da Vinci X Systems 1 1 4 2 1 1 1 1 — — — 8 4 —
Dual Console da Vinci Xi Systems 36 17 28 36 18 5 10 11 3 3 3 117 44 9
Single Console da Vinci Xi Systems 94 54 71 62 34 26 18 23 19 37 37 281 101 93
Dual Console da Vinci 5 Systems — 4 8 45 35 56 73 116 82 109 116 57 280 307
Single Console da Vinci 5 Systems 8 66 102 126 111 122 155 144 110 102 158 302 532 370
Da Vinci SP Systems 9 7 6 13 5 6 6 9 12 16 21 35 26 49
Total System Units Placed (1) 148 149 219 284 204 216 263 304 226 267 335 800 987 828
Trade-Ins, Lease Upgrades, and Retirements (2) (16) (7) (22) (59) (54) (86) (127) (163) (113) (129) (143) (104) (430) (385)
Ending da Vinci System Installed Base 5,243 5,385 5,582 5,807 5,957 6,087 6,223 6,364 6,477 6,615 6,807 5,807 6,364 6,807
(1) Includes da Vinci system units placed under the following operating leasing arrangements:
Fixed-Payment 25 28 35 37 46 45 82 53 69 69 79 125 226 217
Usage-Based 86 86 134 131 94 110 101 131 98 118 144 437 436 360
(2) During the fourth quarter of 2025 and 2024, we performed a verification audit of our installed base records that identified 16 and 25 systems, respectively, mostly older S and Si models, which had been retired.
We removed these systems from our installed base estimate during the fourth quarters of 2025 and 2024, respectively.
OUS da Vinci System Installed Base Rollforward
Beginning da Vinci System Installed Base 3,495 3,644 3,818 3,957 4,095 4,232 4,401 4,540 4,742 4,918 5,095 3,495 4,095 4,742
Systems Placed:
Dual Console da Vinci X Systems — 3 — 2 — 2 1 3 3 — 1 5 6 4
Single Console da Vinci X Systems 37 37 43 45 37 46 40 34 38 58 36 162 157 132
Dual Console da Vinci Xi Systems 22 27 17 40 22 16 24 21 31 16 20 106 83 67
Single Console da Vinci Xi Systems 91 111 85 102 89 96 63 101 71 70 92 389 349 233
Dual Console da Vinci 5 Systems — — — 1 — — 4 14 11 5 8 1 18 24
Single Console da Vinci 5 Systems — — — 2 1 2 8 29 29 30 33 2 40 92
Da Vinci SP Systems 15 14 15 17 14 17 24 26 22 22 21 61 81 65
Total System Units Placed (1) 165 192 160 209 163 179 164 228 205 201 211 726 734 617
Trade-Ins, Lease Upgrades, and Retirements (2) (16) (18) (21) (71) (26) (10) (25) (26) (29) (24) (19) (126) (87) (72)
Ending da Vinci System Installed Base 3,644 3,818 3,957 4,095 4,232 4,401 4,540 4,742 4,918 5,095 5,287 4,095 4,742 5,287
(1) Includes da Vinci system units placed under the following operating leasing arrangements:
Fixed-Payment 40 55 44 45 45 24 34 47 56 54 52 184 150 162
Usage-Based 8 6 7 9 13 14 14 19 20 13 16 30 60 49
(2) During the fourth quarters of 2025 and 2024, we performed a verification audit of our installed base records that identified 6 and 29 systems, respectively, mostly older S and Si models, which had been retired.
We removed these systems from our installed base estimate during the fourth quarters of 2025 and 2024, respectively.
Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 FY24 FY25 FY26
YTD
Intuitive Surgical, Inc.
Trended Unaudited Quarterly and Annual Procedures, Revenue, and Related Metrics
Da Vinci by Geography
2024 - 2026
Page 7 of 12

-- 7 of 12 --

Revenue and Related Metrics
Ion Instruments and Accessories Revenue (millions) $ 44.5 $ 57.7 $ 58.1 $ 61.9 $ 67.7 $ 77.5 $ 84.0 $ 88.3 $ 95.2 $ 109.1 $ 111.2 $ 222.2 $ 317.5 $ 315.5
Year-over-year growth 83% 84% 79% 62% 52% 34% 45% 43% 41% 41% 32% 76% 43% 38%
Quarter-over-quarter growth 17% 30% 1% 7% 9% 14% 8% 5% 8% 15% 2%
Year-over-year Ion procedure growth 91% 83% 72% 70% 57% 52% 52% 44% 39% 36% 31% 78% 51% 35%
Quarter-over-quarter Ion procedure growth 19% 19% 7% 12% 10% 15% 7% 6% 6% 12% 4%
Ion Service Revenue (millions) $ 7.2 $ 8.5 $ 10.0 $ 10.8 $ 11.2 $ 12.5 $ 13.1 $ 13.8 $ 14.4 $ 16.9 $ 16.1 $ 36.5 $ 50.6 $ 47.4
Year-over-year growth 64% 70% 79% 69% 56% 47% 31% 28% 29% 35% 23% 71% 39% 29%
Quarter-over-quarter growth 13% 18% 18% 8% 4% 12% 5% 5% 4% 17% (5)%
Ion Systems Revenue (millions) $ 26.3 $ 29.7 $ 26.4 $ 31.2 $ 27.9 $ 24.1 $ 34.4 $ 33.9 $ 28.3 $ 32.3 $ 31.4 $ 113.6 $ 120.3 $ 92.0
Year-over-year growth (decline) 39% 27% 15% 94% 6% (19)% 30% 9% 1% 34% (9)% 40% 6% 6%
Quarter-over-quarter growth (decline) 63% 13% (11)% 18% (11)% (14)% 43% (1)% (17)% 14% (3)%
Total Ion Revenue (millions) $ 78.0 $ 95.9 $ 94.5 $ 103.9 $ 106.8 $ 114.1 $ 131.5 $ 136.0 $ 137.9 $ 158.3 $ 158.7 $ 372.3 $ 488.4 $ 454.9
Year-over-year growth 64% 60% 55% 71% 37% 19% 39% 31% 29% 39% 21% 63% 31% 29%
Quarter-over-quarter growth (decline) 29% 23% (1)% 10% 3% 7% 15% 3% 1% 15% —%
Ion System Installed Base Rollforward
Beginning Ion System Installed Base 534 604 678 736 805 853 905 954 995 1,041 1,096 534 805 995
Systems Placed (1) 70 74 58 69 49 54 50 42 52 55 56 271 195 163
Trade-Ins and Retirements — — — — (1) (2) (1) (1) (6) — — — (5) (6)
Ending Ion System Installed Base (2) 604 678 736 805 853 905 954 995 1,041 1,096 1,152 805 995 1,152
Ending Ion Installed System Base – U.S. 597 669 722 784 828 873 913 948 986 1,028 1,072 784 948 1,072
Ending Ion Installed System Base – OUS 7 9 14 21 25 32 41 47 55 68 80 21 47 80
(1) Includes Ion Systems Placed under Operating Lease
Arrangements 39 40 36 38 29 34 17 16 36 31 26 153 96 93
(2) Includes Ion System Installed Base under Operating
Lease Arrangements 244 275 296 319 334 358 362 360 380 397 411 319 360 411
Other Metrics (in thousands)
Ion Procedures 19.5 23.2 24.9 27.9 30.7 35.3 37.9 40.2 42.7 47.9 49.7 95.5 144.1 140.3
Ion Instruments and Accessories Revenue per Procedure $ 2.28 $ 2.49 $ 2.33 $ 2.22 $ 2.21 $ 2.20 $ 2.22 $ 2.20 $ 2.23 $ 2.28 $ 2.24 $ 2.33 $ 2.20 $ 2.25
Ion System Average Selling Price $ 550 $ 570 $ 590 $ 580 $ 550 $ 610 $ 580 $ 590 $ 630 $ 650 $ 590 $ 570 $ 580 $ 620
Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 FY24 FY25 FY26
YTD
Intuitive Surgical, Inc.
Trended Unaudited Quarterly and Annual Procedures, Revenue, and Related Metrics
Ion Worldwide
2024 - 2026
Page 8 of 12

-- 8 of 12 --

GAAP gross profit $ 1,245.4 $ 1,372.7 $ 1,373.9 $ 1,642.2 $ 1,457.7 $ 1,617.9 $ 1,662.4 $ 1,904.3 $ 1,830.5 $ 1,960.4 $ 2,084.3 $ 5,634.2 $ 6,642.3 $ 5,875.2
GAAP gross profit margin (1) 65.9% 68.3% 67.4% 68.0% 64.7% 66.3% 66.4% 66.4% 66.1% 67.8% 68.4% 67.5% 66.0% 67.4%
Share-based compensation expense 29.1 29.7 31.3 33.6 36.2 36.6 38.8 35.5 36.0 36.2 36.6 123.7 147.1 108.8
Long-term incentive plan expense 0.3 0.1 0.2 0.2 0.3 0.1 0.2 (0.1) 0.1 (0.1) — 0.8 0.5 —
Amortization of intangible assets 3.8 3.7 2.4 2.4 2.4 2.5 2.4 2.4 6.6 23.3 8.7 12.3 9.7 38.6
Acquisition-related items — — — — — — — — 5.9 4.1 — — — 10.0
Non-GAAP gross profit $ 1,278.6 $ 1,406.2 $ 1,407.8 $ 1,678.4 $ 1,496.6 $ 1,657.1 $ 1,703.8 $ 1,942.1 $ 1,879.1 $ 2,023.9 $ 2,129.6 $ 5,771.0 $ 6,799.6 $ 6,032.6
Non-GAAP gross profit margin (2) 67.6% 70.0% 69.1% 69.5% 66.4% 67.9% 68.0% 67.8% 67.8% 70.0% 69.9% 69.1% 67.6% 69.2%
GAAP SG&A expenses $ 491.5 $ 525.3 $ 510.6 $ 612.6 $ 563.4 $ 561.2 $ 573.3 $ 687.1 $ 613.3 $ 617.9 $ 1,083.4 $ 2,140.0 $ 2,385.0 $ 2,314.6
Share-based compensation expense (66.6) (78.3) (76.3) (77.7) (80.2) (85.0) (87.3) (88.1) (91.7) (87.1) (88.5) (298.9) (340.6) (267.3)
Long-term incentive plan expense (1.9) (0.9) (1.0) (1.0) (0.5) (0.2) (1.1) 1.3 (0.4) 0.3 (0.3) (4.8) (0.5) (0.4)
Amortization of intangible assets (0.8) (0.8) (0.6) (0.2) (0.5) (0.1) (0.1) — (0.2) (0.5) (0.5) (2.4) (0.7) (1.2)
Facilities asset abandonment charge — — — — — — — — — (6.9) — — — (6.9)
Litigation charges — (7.2) — (12.6) — (3.5) (8.1) (2.0) (6.3) — (454.9) (19.8) (13.6) (461.2)
Gains on sale of businesses and assets — — — 1.1 — — — 1.0 7.9 — — 1.1 1.0 7.9
Acquisition-related items — — — — — — — — (0.1) (1.6) — — — (1.7)
Non-GAAP SG&A expenses $ 422.2 $ 438.1 $ 432.7 $ 522.2 $ 482.2 $ 472.4 $ 476.7 $ 599.3 $ 522.5 $ 522.1 $ 539.2 $ 1,815.2 $ 2,030.6 $ 1,583.8
GAAP R&D expenses $ 284.5 $ 280.1 $ 286.0 $ 294.7 $ 316.2 $ 313.3 $ 329.4 $ 352.9 $ 361.9 $ 370.6 $ 408.3 $ 1,145.3 $ 1,311.8 $ 1,140.8
Share-based compensation expense (57.6) (65.6) (65.3) (65.7) (68.8) (74.6) (77.4) (79.6) (81.8) (86.6) (87.5) (254.2) (300.4) (255.9)
Amortization of intangible assets (0.5) (0.5) (0.5) (0.5) (0.5) (0.6) (0.8) (0.9) (0.3) (0.2) (0.1) (2.0) (2.8) (0.6)
Non-GAAP R&D expenses $ 226.4 $ 214.0 $ 220.2 $ 228.5 $ 246.9 $ 238.1 $ 251.2 $ 272.4 $ 279.8 $ 283.8 $ 320.7 $ 889.1 $ 1,008.6 $ 884.3
GAAP income from operations $ 469.4 $ 567.3 $ 577.3 $ 734.9 $ 578.1 $ 743.4 $ 759.7 $ 864.3 $ 855.3 $ 971.9 $ 592.6 $ 2,348.9 $ 2,945.5 $ 2,419.8
GAAP operating margin (3) 24.8% 28.2% 28.3% 30.4% 25.7% 30.5% 30.3% 30.2% 30.9% 33.6% 19.4% 28.1% 29.3% 27.8%
Share-based compensation expense 153.3 173.6 172.9 177.0 185.2 196.2 203.5 203.2 209.5 209.9 212.6 676.8 788.1 632.0
Long-term incentive plan expense 2.2 1.0 1.2 1.2 0.8 0.3 1.3 (1.4) 0.5 (0.4) 0.3 5.6 1.0 0.4
Amortization of intangible assets 5.1 5.0 3.5 3.1 3.4 3.2 3.3 3.3 7.1 24.0 9.3 16.7 13.2 40.4
Facilities asset abandonment charge — — — — — — — — — 6.9 — — — 6.9
Litigation charges — 7.2 — 12.6 — 3.5 8.1 2.0 6.3 — 454.9 19.8 13.6 461.2
Gains on sale of businesses and assets — — — (1.1) — — — (1.0) (7.9) — — (1.1) (1.0) (7.9)
Acquisition-related items — — — — — — — — 6.0 5.7 — — — 11.7
Non-GAAP income from operations $ 630.0 $ 754.1 $ 754.9 $ 927.7 $ 767.5 $ 946.6 $ 975.9 $ 1,070.4 $ 1,076.8 $ 1,218.0 $ 1,269.7 $ 3,066.7 $ 3,760.4 $ 3,564.5
Non-GAAP operating margin (4) 33.3% 37.5% 37.0% 38.4% 34.1% 38.8% 39.0% 37.3% 38.9% 42.1% 41.6% 36.7% 37.4% 40.9%
Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 FY24 FY25 FY26
YTD
Intuitive Surgical, Inc.
Reconciliation of Unaudited GAAP to Non-GAAP Financial Measures (#)
(in millions, except per share data)
2024 - 2026
Page 9 of 12

-- 9 of 12 --

GAAP income before taxes $ 538.5 $ 654.5 $ 671.0 $ 809.8 $ 668.5 $ 832.1 $ 855.2 $ 955.6 $ 940.4 $ 1,054.6 $ 668.4 $ 2,673.8 $ 3,311.4 $ 2,663.4
Share-based compensation expense 153.3 173.6 172.9 177.0 185.2 196.2 203.5 203.2 209.5 209.9 212.6 676.8 788.1 632.0
Long-term incentive plan expense 2.2 1.0 1.2 1.2 0.8 0.3 1.3 (1.4) 0.5 (0.4) 0.3 5.6 1.0 0.4
Amortization of intangible assets 5.1 5.0 3.5 3.1 3.4 3.2 3.3 3.3 7.1 24.0 9.3 16.7 13.2 40.4
Facilities asset abandonment charge — — — — — — — — — 6.9 — — — 6.9
Litigation charges — 7.2 — 12.6 — 3.5 8.1 2.0 6.3 — 454.9 19.8 13.6 461.2
Gains on sale of businesses and assets — — — (1.1) — — — (1.0) (7.9) — — (1.1) (1.0) (7.9)
Acquisition-related items — — — — — — — — 6.0 5.7 — — — 11.7
(Gains) losses on strategic investments 3.4 (7.8) 0.9 12.7 0.6 4.4 (3.0) (4.9) (0.6) (0.2) (0.9) 9.2 (2.9) (1.7)
Non-GAAP income before taxes $ 702.5 $ 833.5 $ 849.5 $ 1,015.3 $ 858.5 $ 1,039.7 $ 1,068.4 $ 1,156.8 $ 1,161.3 $ 1,300.5 $ 1,344.6 $ 3,400.8 $ 4,123.4 $ 3,806.4
GAAP net income attributable to Intuitive $ 544.9 $ 526.9 $ 565.1 $ 685.7 $ 698.4 $ 658.4 $ 704.4 $ 794.8 $ 821.5 $ 818.1 $ 522.8 $ 2,322.6 $ 2,856.0 $ 2,162.4
Share-based compensation expense 153.3 173.6 172.9 177.0 185.2 196.2 203.5 203.2 209.5 209.9 212.6 676.8 788.1 632.0
Long-term incentive plan expense 2.2 1.0 1.2 1.2 0.8 0.3 1.3 (1.4) 0.5 (0.4) 0.3 5.6 1.0 0.4
Amortization of intangible assets 5.1 5.0 3.5 3.1 3.4 3.2 3.3 3.3 7.1 24.0 9.3 16.7 13.2 40.4
Facilities asset abandonment charge — — — — — — — — — 6.9 — — — 6.9
Litigation charges — 7.2 — 12.6 — 3.5 8.1 2.0 6.3 — 454.9 19.8 13.6 461.2
Gains on sale of businesses and assets — — — (1.1) — — — (1.0) (7.9) — — (1.1) (1.0) (7.9)
Acquisition-related items — — — — — — — — 6.0 5.7 — — — 11.7
(Gains) losses on strategic investments 3.4 (7.8) 0.9 12.7 0.6 4.4 (3.0) (4.9) (0.6) (0.2) (0.9) 9.2 (2.9) (1.7)
Tax adjustments (167.0) (64.5) (74.0) (86.0) (226.6) (67.8) (49.9) (82.7) (141.1) (62.1) (144.4) (391.5) (427.0) (347.6)
Adjustments attributable to noncontrolling interest in
joint venture (0.8) (0.4) (0.5) (0.5) (0.3) (0.3) (0.5) 0.3 (0.2) 0.2 (0.1) (2.2) (0.8) (0.1)
Non-GAAP net income attributable to Intuitive $ 541.1 $ 641.0 $ 669.1 $ 804.7 $ 661.5 $ 797.9 $ 867.2 $ 913.6 $ 901.1 $ 1,002.1 $ 1,054.5 $ 2,655.9 $ 3,240.2 $ 2,957.7
Non-GAAP net income per share attributable to
Intuitive - diluted $ 1.50 $ 1.78 $ 1.84 $ 2.21 $ 1.81 $ 2.19 $ 2.40 $ 2.53 $ 2.50 $ 2.80 $ 3.00 $ 7.34 $ 8.93 $ 8.30
Diluted shares outstanding 360.5 361.0 362.7 363.9 364.6 364.1 361.8 360.4 359.8 357.3 351.6 362.0 362.7 356.2
(1) GAAP gross profit margin is calculated by dividing GAAP gross profit by revenue.
(2) Non-GAAP gross profit margin is calculated by dividing non-GAAP gross profit by revenue.
(3) GAAP operating margin is calculated by dividing GAAP income from operations by revenue.
(4) Non-GAAP operating margin is calculated by dividing non-GAAP income from operations by revenue.
Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 FY24 FY25 FY26
YTD
Intuitive Surgical, Inc.
Reconciliation of Unaudited GAAP to Non-GAAP Financial Measures (#)
(in millions, except per share data)
2024 - 2026
Page 10 of 12

-- 10 of 12 --

This information is supplemental to the third quarter 2026 earnings press release issued by Intuitive Surgical, Inc., on
October 20, 2026, and should be read in conjunction with that release and the Company’s Quarterly Report on Form 10-Q for
the period ended September 30, 2026, when filed with the U.S. Securities and Exchange Commission.
(#) About Non-GAAP Financial Measures
To supplement our consolidated financial statements, which are prepared and presented in accordance with accounting
principles generally accepted in the United States (“GAAP”), we use the following non-GAAP financial measures: non-
GAAP gross profit, non-GAAP gross profit margin, non-GAAP SG&A expenses, non-GAAP research and development
(“R&D”) expenses, non-GAAP income from operations, non-GAAP operating margin, non-GAAP income before taxes, non-
GAAP net income attributable to Intuitive, and non-GAAP net income per diluted share attributable to Intuitive (“EPS”). The
presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the
financial information prepared and presented in accordance with GAAP.
We use these non-GAAP financial measures for financial and operational decision-making and as a means to evaluate period-
to-period comparisons. We believe that these non-GAAP financial measures provide meaningful supplemental information
regarding our performance by excluding items such as amortization of intangible assets, share-based compensation (“SBC”)
and long-term incentive plan (“LTIP”) expenses, and other special items. LTIP expense relates to phantom share awards
granted in China by our Intuitive-Fosun joint venture, to its employees that vest over four years and can remain outstanding
for seven to ten years. These awards are valued based on certain key performance metrics. Accordingly, they are subject to
significant volatility based on the performance of these metrics and are not tied to performance of our business within the
period. We believe that both management and investors benefit from referring to these non-GAAP financial measures in
assessing our performance and when planning, forecasting, and analyzing future periods. These non-GAAP financial
measures also facilitate management’s internal comparisons to our historical performance. We believe that these non-GAAP
financial measures are useful to investors, because (1) they allow for greater transparency with respect to key metrics used by
management in its financial and operational decision-making, and (2) they are used by institutional investors and the analyst
community to help them analyze the performance of our business.
Non-GAAP gross profit. We define non-GAAP gross profit as gross profit, excluding SBC and LTIP expenses, amortization
of intangible assets, and acquisition-related items.
Non-GAAP SG&A expenses. We define non-GAAP SG&A expenses as SG&A expenses, excluding SBC and LTIP expenses,
amortization of intangible assets, a facilities asset abandonment charge, litigation charges, gains on the sale of businesses and
assets, and acquisition-related items.
Non-GAAP R&D expenses. We define non-GAAP R&D expenses as R&D expenses, excluding SBC expenses and
amortization of intangible assets.
Non-GAAP income from operations. We define non-GAAP income from operations as income from operations, excluding
SBC and LTIP expenses, amortization of intangible assets, a facilities asset abandonment charge, litigation charges, gains on
the sale of businesses and assets, and acquisition-related items.
Non-GAAP income before taxes. We define non-GAAP income before taxes as income before taxes, excluding SBC and
LTIP expenses, amortization of intangible assets, a facilities asset abandonment charge, litigation charges, gains on the sale
of businesses and assets, acquisition-related items, and gains (losses) on strategic investments.
Non-GAAP net income attributable to Intuitive and EPS. We define non-GAAP net income as net income attributable to
Intuitive, excluding SBC and LTIP expenses, amortization of intangible assets, a facilities asset abandonment charge,
litigation charges, gains on the sale of businesses and assets, acquisition-related items, gains (losses) on strategic investments,
tax adjustments, including excess tax benefits associated with SBC arrangements and the net tax effects related to intra-entity
transfers of non-inventory assets, and adjustments attributable to noncontrolling interest in joint venture, net of the related tax
effects. We exclude the excess tax benefits associated with SBC arrangements as well as the tax effects associated with non-
cash amortization of deferred tax assets related to intra-entity non-inventory transfers, because we do not believe these items
correlate with the on-going results of our core operations. The tax effects of the non-GAAP items are determined by applying
a calculated non-GAAP effective tax rate, which is commonly referred to as the with-and-without method. Without excluding
these tax effects, investors would only see the gross effect that these non-GAAP adjustments had on our operating results.
Our calculated non-GAAP effective tax rate is generally higher than our GAAP effective tax rate. We define non-GAAP EPS
as non-GAAP net income attributable to Intuitive divided by diluted shares outstanding, which are calculated as GAAP
weighted-average outstanding shares plus dilutive potential shares outstanding during the period.
There are a number of limitations related to the use of non-GAAP measures versus measures calculated in accordance with
GAAP. Non-GAAP gross profit, non-GAAP SG&A expenses, non-GAAP R&D expenses, non-GAAP income from
Page 11 of 12

-- 11 of 12 --

operations, non-GAAP income before taxes, non-GAAP net income attributable to Intuitive, and non-GAAP EPS exclude
items such as amortization of intangible assets, SBC and LTIP expenses, excess tax benefits associated with SBC
arrangements, and non-cash amortization of deferred tax assets related to intra-entity transfer of non-inventory assets, which
are primarily recurring items. SBC expense has been, and will continue to be for the foreseeable future, a significant recurring
expense in our business. In addition, the components of the costs that we exclude in our calculation of non-GAAP net income
attributable to Intuitive and non-GAAP EPS may differ from the components that our peer companies exclude when they
report their results of operations. Management addresses these limitations by providing specific information regarding the
GAAP amounts excluded from non-GAAP net income attributable to Intuitive and non-GAAP EPS and evaluating non-
GAAP net income attributable to Intuitive and non-GAAP EPS together with net income attributable to Intuitive and net
income per share attributable to Intuitive calculated in accordance with GAAP.
Page 12 of 12

-- 12 of 12 --